About this trial
This study is to investigate the efficacy of Targeted Microwave Ablation (TMA) under MRI-Ultrasound fusion and organ-based tracking (OBT) navigation in localized prostate cancer (PCa) in a multi-centre trial.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
ISUP grade group 2 or 3 PCa
Systematic biopsies showing grade group 1-3 PCa just next to the MRI lesion is allowed
Systematic biopsies showing grade group 1 PCa far away from the lesion is allowed
Disqualifiers
None
Trial design
Single group
Treatments tested in this trial
Targeted Microwave Ablation (TMA) for localized prostate cancer using organ based tracking (OBT) navigation
DeviceTargeted microwave ablation (TMA) is a novel treatment developed for focal treatment of prostate cancer, and it is applied with precise navigation guidance under the organ-based tracking (OBT) mechanism.
Treatment groups
Trial outcomes
Primary outcomes
The oncological control of prostate cancer
Any clinically significant PCa (csPCa) detected on biopsy of treated area(s) per patient at 12 months after treatment, defined by: • ISUP grade group 2 or above PCa
Secondary outcomes
Clinically significant cancer detection on biopsy of each ablated MRI visible lesion
Per-lesion analysis of csPCa detected on biopsy of any ablated areas at 12 months
Cancer detection on biopsy of each ablated MRI invisible lesion
Per-lesion analysis of any cancer detected on biopsy of any ablated areas at 12 months
Out-of-field recurrence: Any cancer outside treated area on systematic biopsy
Out-of-field recurrence: Any cancer outside treated area on systematic biopsy
Common Terminology Criteria for Adverse Events (CTCAE) v5.0
Complications of treatment using Common Terminology Criteria for Adverse Events (CTCAE) v5.0
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Chinese University of Hong Kong
Lead sponsor
Princess Margaret Hospital, Hong Kong
Collaborator
Siriraj Hospital
Collaborator
Universiti Putra Malaysia
Collaborator
Chinese General Hospital and Medical Center, Philippines
Collaborator